What Makes A “Breakthrough”?
This article was originally published in RPM Report
Executive Summary
FDA is still not ready to draw any clear line defining what qualifies for the new “Breakthrough” therapy designation, but most successful applicants have presented data showing more than a 50% improvement versus standard therapy on some important endpoint.